Introduction

I
n this study we compare quality of life (QOL) of people living with cancer, either currently or as a past experience with people who have not experienced cancer in 19 European countries. We further use multilevel modelling to examine whether the relationship between cancer status and QOL varies between countries in general, and by welfare state regimes in particular.
QOL has been defined and measured in different ways. 1 Researchers often distinguish between general (or global) QOL and health-related QOL (HRQOL). The main difference between measurements of QOL and HRQOL is that the latter are multidimensional instruments based mainly on functional status, whereas QOL measures the individual's subjective evaluation of their life and well-being. Whereas HRQOL instruments may be more valuable and precise in measuring the effects of treatments, they mostly tap into negative aspects of functioning rather than general experiences of QOL in terms of life satisfaction and happiness as used in our study.
Research concur with the common sense expectation in that experiencing a cancer disease is likely to have a deteriorating effect on QOL. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] This leads us to expect that QOL, as measured by life satisfaction and happiness, will be best in the non-cancer group; followed by the group who previously have had cancer, and QOL will be poorest among persons who currently are living with cancer. We will also use multilevel modelling to test whether the differences in QOL between the groups by cancer status varies across countries.
Welfare state typologies group countries with similar features into a number of welfare state regime based on criteria such as the generosity of social benefits and services and whether entitlement is universal or means tested. Esping-Andersen 15 classified welfare states into Liberal, Conservative and Social Democratic welfare regimes. Ferrera added a Southern regime. The Scandinavian (Social Democratic) regime is characterized by a generous and universal social protection. The Bismarckian (Conservative) regime has a strong link between work position and entitlement. In the Anglo-Saxon (Liberal) regime, social benefits and services are means tested, but fairly generous. The Southern regime is a fragmented system of income guarantees linked to the work position. 16 In addition we add an Eastern welfare regime to include the former communist countries in Eastern Europe. They are relatively poor with limited health services. Welfare regimes have been shown to be related to both happiness and subjective general health. 17, 18 Thus, we would expect substantial differences in QOL between welfare regimes. Furthermore, the differences in level of welfare provision and medical services between welfare regimes may affect the differences in QOL by cancer status. However, since the physical experience of cancer diseases most likely is uniform across countries, this may be more important for the QOL of cancer patients than the differences in welfare provision.
Based on current research, [17] [18] [19] we control for confounding by adding socio-demographic variables (age, gender, education) and two indicators of social support, which is well known to be associated with QOL as well as health. 17, 19 
Methods
The data source was the European Social Survey (ESS) 2014 covering 21 European countries. 20 Two countries, the Czech Republic and Hungary were excluded due to errors related to the question on cancer status. The net sample was restricted to respondents aged 25-75. The youngest was excluded because of very low prevalence of cancer and the upper age limit of 75 was set rather arbitrary to avoid the sample selection bias for respondents with advanced age.
Measurements
The QOL scale is the mean score of the two questions on life satisfaction and happiness (Cronbach's = 0.82). The question on life satisfaction was phrased in this way: 'All things considered, how satisfied are you with your life as a whole nowadays? Please answer using this card, where 0 means extremely dissatisfied and 10 means extremely satisfied'. The question on happiness was similarly phrased: 'Taking all things together, how happy would you say you are? Please use this card'. The card pictured a response scale from 0 to 10 where the ends were labelled; 0 'Extremely unhappy' and 10 'Extremely happy'. In addition to using the QOL scale as a continuous variable, we constructed a second dependent variable, Poor QOL, with the value of 1 for people with QOL-scores 5.0, and 0 otherwise. About 15% of the respondents had low QOL by this definition.
The main explanatory variable is the threefold classification of cancer status. The question was posed in an indirect way due to its sensitivity: 'Do you have or have you ever had any of the health problems listed on this card. 'If yes', is this current or previously'. The following health problems were listed on the showcard: Cancer affecting any part of the body; Leukaemia; Malignant tumour; Malignant lymphoma; Melanoma, carcinoma, or other skin cancer. The interviewer registered the following codes: 'Yes, currently', 'Yes, previously', 'No, never', which is the basis of our classification of cancer status. The estimated cancer prevalence for the net sample, and for groups by age, gender and country are shown in Table 1 . An estimated 4.2% reported to currently (autumn 2014) having cancer. Another 6.6% reported that they previously have had cancer. The prevalence varied by age and slightly by gender and the welfare state classification.
The 19 countries were located in the five-category welfare state classification: Scandinavian (Denmark, Finland, Norway and Sweden); Bismarckian (Austria, Belgium, France, Germany, the Netherlands and Switzerland); Anglo-Saxon (UK and Ireland); Southern (Israel, Portugal and Spain); Eastern (Estonia, Lithuania, Poland and Slovenia.
To adjust for confounding we included age in three categories (25-40, 41-60, 61-75), gender, education (Primary/Lower Secondary, Secondary, Tertiary) and two indicators of social support; whether the respondent was living together with a partner, and the number of people 'with whom you can discuss intimate and personal matters'. We collapsed the distribution of the latter variable to three categories: 0-1, 2-3, 4+.
Multilevel modelling
The net sample has a two-level structure with 28 576 respondents in 19 countries. The basic two-level random intercept models may be expressed in the following two equations 21 :
The regression model :
The logit model :
Y ij , the continuous QOL scale, is the dependent variables in two-level regression model, and L ij , the logit of the probability of poor QOL, is the dependent variable in the two-level logit model. The constants (intercepts) in both model may vary randomly across countries. This variation (around b 0 ) is captured by the level 2 residual, u 0j . The explanatory variables are represented by b k x ik . The multilevel models were estimated by using the programmes 'mixed' and the 'melogit' in Stata 14 (www.stata.com). Our analytical strategy for the multilevel modelling was to start with the null model (without explanatory variables), that allows for the estimation of the intra-correlation coefficient (ICC). Next, we examined whether a model where the coefficients pertaining to cancer status showed between-country variation. Finally, we tested whether the interaction between cancer status and the welfare state classification was statistically significant. Since, the test was negative the final model (Table 3) includes only the main effects of cancer status and the welfare state classification.
Results
The estimates from the null model (ICC = 0.112 for QOL scale; ICC = 0.149 for Poor QOL) showed that more than ten percent of the variation in the QOL scores stemmed from between-country differences and this implies that multilevel analysis was appropriate. Next, we estimated the unadjusted effects of cancer status and the welfare state classification ( Table 2 ). The unadjusted difference on the QOL scale between those currently with cancer and people without the experience with cancer was around 0.8 on a scale from 0 to 10, (b = À0.76, t = À5.31, P < 0.001). For Poor QOL, the corresponding odds ratio (OR) was 2.38, 95% CI (2.07, 2.74). People who previously have had cancer also reported lower QOL than those who never had experienced cancer, but the differences were small; b = À0.16, P < 0.001 and OR = 1.25, 95% CI (1.09, 1.42).
As expected there were substantial differences in QOL among the welfare regimes, with the highest QOL-score for the Scandinavian regime and the lowest for the Eastern one. For Poor QOL, the largest OR was for the comparison of the Eastern regime with the Scandinavian one, OR Un = 6.33, 95% CI (3.52, 11.26) and OR Adj = 4.96, 95% CI (2.94, 8.38).
Having established that both our explanatory variables were related to the two indicators of general QOL, the next step was to establish whether the effects of cancer status on QOL varied across countries, or more specifically between the welfare state regimes. The first way of doing this was to test whether the two coefficients for cancer status in the regression and the logit models showed significant between-country variation. A likelihood-ratio (LR) test gave a statistical significant outcome for the QOL scale ( 2 = 42.97, df = 2, P < 0.001), but for Poor QOL, the model did not converge. This was followed by adding terms representing the statistical interaction between cancer status and the welfare state classification to the full model with controls for confounding. This was a direct test of whether people with the experience of cancer in welfare regimes with higher levels of welfare provision, such as the Scandinavian regime, would report higher QOL scores than cancer victims in the Southern and Eastern welfare state regimes. For both dependent variables, the LR tests were negative; for the QOL scale, ( 2 = 12.24, df = 8, P < 0.15), and for Poor QOL, ( 2 = 9.52, df = 8, P < 0.31). Thus, the final models reported in Table 3 are without the statistical interaction between cancer status and welfare regimes.
After adjustment (Table 3) the difference between the 'Currently' and the 'Never' category was somewhat smaller than the unadjusted difference (b = À0.52, t = 5.75, P < 0.001). The differences between the 'Previously' and the 'Never' groups were small but statistical significant for both the unadjusted and the adjusted coefficients (b = À0.12, P < 0.05; OR = 1.16 95% CI (1.02, 1.34).
For Poor QOL, the adjusted OR was reduced from 2.38 to OR = 1.98, 95% CI (1.71, 2.30) while the OR comparing the 'Previously' with the 'Never' groups was small but still statistical significant [OR = 1.16, 95% CI (1.02, 1.34)]. Table 3 also describes the general QOL in groups by age, gender and levels of education. Levels of education and the two indicators of social support were strong predictors of QOL, whereas there were only minor differences in QOL by age and gender.
Discussion
We have compared three groups in terms of QOL: people who currently have cancer, people who previously have had cancer, and people who never had experienced cancer. Those currently with cancer scored about 0.5 lower than people who never had experienced cancer and they had two times higher odds on having poor QOL compared with the latter group. The unadjusted and the adjusted differences between the 'Previously' and the 'Never' groups were statistical significant for both the continuous scale and for Poor QOL, but the differences were small. The multilevel analysis of the QOL scale indicated that these group differences may vary among the countries. Although the welfare state classification was a powerful predictor of QOL, the multilevel analysis indicated that the variation in the differences between the groups by cancer status cannot be explained by the welfare state classification. In other words, our study does not indicate that people with a cancer disease fare better in terms of QOL in welfare state regimes with high level of provisions compared with regimes with a more basic services. This needs to be further explored, however, since the statistical power of our data to reveal such differences is limited.
Due to the scarcity of studies based on general QOL, we mainly compare ours with studies based on HRQOL. Quinten et al. 2 found that cancer patients generally are impaired in terms of HRQOL compared with the general population, although this varied by domains of HRQOL. Some American studies based on large-scale data from the Medicare Health Outcomes Survey [9] [10] [11] [12] show that cancer patients reported significantly poorer physical and mental health compared with patients without cancer. 12 The HRQOL differences were greater for physical dimensions than for mental dimensions. 2 The study by Baker et al. 9 indicated that newly diagnosed cancer patients had poorer QOL compared with both long-time survivors and to the non-cancer group. Three European studies based on small samples reported findings largely consistent with the large-scale American studies. 6, 13, 14 Studies of long-term cancer survivors compared with various control groups have similarity with our comparison of people who previously have had cancer and the general population. [3] [4] [5] 7 One of the studies 5 indicated that long-term surviving head-and-neck cancer patients had reduced life satisfaction compared with matched control groups from a general population. However, the other studies [3] [4] 7 did not indicate significant differences in QOL between long-time cancer survivors and various reference samples.
In summary, most studies, with different measurements of QOL, have shown lower HRQOL in cancer patients compared with various control samples, although there is variation across domains of HRQOL. This is largely consistent with our results comparing people who reported to have cancer and those who never had experienced cancer. Also, consistent with earlier studies, we found only minor differences in QOL between persons who previously have had cancer (survivors) and those who never have had cancer. Leaning on the study of Baker et al., 9 the most reasonable interpretation is that cancer survivors over time gradually catch-up with the general population in terms of general QOL.
Our study has limitations. First, the cancer status classification is a crude self-reported measurement not based upon clinical diagnoses and we do not have information on the type of cancer. Therefore, it is only possible to provide a general picture of the cancer population, although there may be differences in QOL between cancer types with good prognoses, such as breast cancer and types with poorer prognoses such as liver-and lung cancer. We do not have information on other serious diseases that might affect QOL. For those who reported to have had cancer previously, we lack information on when they became cancer-free. In sum, although the data set has limitations in the level of details, we do not think these limitations bias our findings in any particular direction. Finally, although we cannot conclusively exclude the possibility that cultural traits may explain some of the between-country differences in QOL, a study on potential cultural measurement bias in happiness does indicate this is not the case. 22 To our knowledge our study is the first one to compare the general QOL by cancer status in a large scale cross-national dataset, which also enabled us to examine whether the differences in QOL by cancer status varied by welfare state regimes.
Our study showed that the QOL of people with a cancer disease is significantly impaired. People who previously have had cancer, however, scored only slightly lower on the QOL scale than people who never had experienced cancer. We found evidence indicating that these differences may show variation among the countries, but this variation cannot be explained by the welfare state classification. Cancer patients are generally impaired in terms of QOL, about equally so in all countries.
Our study also indicates that social support (living with a partner, having persons to discuss intimate matters with) is important for QOL. This implies that health care personnel would do well to follow up patients throughout the disease period and work to maintain and strengthen their social networks.
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